IVB103
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IVB103, covering 2025-04-30 to 2025-04-30. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Study of IVB103 Injection in Subjects With Neovascular (Wet) Agerelated Macular Degeneration (nAMD). [Phase 1]